006280.KS
GC Biopharma Corp.
KSC · Healthcare · Medical - Pharmaceuticals · KR
KRW 127,000.00
+0.00%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- KRW 2.0K
- Revenue estimate
- KRW 590.7B
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- KRW 902
- EPS estimate
- KRW 974
- Revenue actual
- KRW 418.1B
- Revenue estimate
- KRW 455.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -3.7%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026